Mycenax Biotech (ROCO:4726) FCF Margin %: 22.60% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4726 Mycenax Biotech Inc ROCO:4726
43 GF Score
Price NT$24.50
GF Value NT$47.88
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mycenax Biotech FCF Margin %?

Mycenax Biotech ROCO:4726 -4.67% 43 FCF Margin % is 22.60% as of Dec. 2025. GuruFocus rates ROCO:4726 with a GF Score™ of 43/100 and a GF Value™ of NT$47.88 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 950 Biotechnology companies, Mycenax Biotech ranks better than 64.42% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mycenax Biotech's Free Cash Flow for the three months ended in Dec. 2025 was NT$64.3 Mil. Mycenax Biotech's Revenue for the three months ended in Dec. 2025 was NT$284.6 Mil. Therefore, Mycenax Biotech's FCF Margin % for the quarter that ended in Dec. 2025 was 22.60%.

As of today, Mycenax Biotech's current FCF Yield % is -2.50%.

The historical rank and industry rank for Mycenax Biotech's FCF Margin % or its related term are showing as below:

ROCO:4726' s FCF Margin % Range Over the Past 10 Years
Min: -177.82   Med: -79.06   Max: -13.24
Current: -17.06

During the past 13 years, the highest FCF Margin % of Mycenax Biotech was -13.24%. The lowest was -177.82%. And the median was -79.06%.

ROCO:4726's FCF Margin % is ranked better than
64.42% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs ROCO:4726: -17.06

Mycenax Biotech FCF Margin % Related Terms

Mycenax Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Mycenax Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mycenax Biotech FCF Margin % Chart

Mycenax Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -162.64 -107.77 -65.70 -76.35 -17.06

Mycenax Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.27 -57.52 -22.54 -57.07 22.60

ROCO:4726 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Mycenax Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mycenax Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mycenax Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Mycenax Biotech's FCF Margin % falls into.


ROCO:4726
43GF Score
Mycenax Biotech Inc ROCO:4726
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mycenax Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Mycenax Biotech's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-126.319/740.238
=-17.06 %

Mycenax Biotech's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=64.304/284.592
=22.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 22.60% mean?
Mycenax Biotech (ROCO:4726) has a FCF Margin % of 22.60% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mycenax Biotech and its competitors. According to the industry distribution chart, Mycenax Biotech ranks #338 out of 950 companies in the Biotechnology industry, placing it in the top 35.6%.
Is Mycenax Biotech's FCF Margin % too high?
Mycenax Biotech's current FCF Margin % is 22.60%. Based on the distribution chart, Mycenax Biotech ranks #338 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Mycenax Biotech has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mycenax Biotech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Mycenax Biotech ranks #338 out of 950 companies for FCF Margin %. This puts Mycenax Biotech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mycenax Biotech and its competitors. Mycenax Biotech's current FCF Margin % is 22.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mycenax Biotech stock overvalued right now?
Based on GuruFocus' analysis, Mycenax Biotech (ROCO:4726) is currently considered Possible Value Trap. The stock's GF Value™ is NT$47.88, compared to a current price of NT$24.50 — trading 48.8% below its estimated fair value. The current FCF Margin % is 22.60%. Mycenax Biotech's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Mycenax Biotech (ROCO:4726), the current FCF Margin % is 22.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mycenax Biotech (ROCO:4726) Overvalued in 2026?

Based on GuruFocus' analysis, Mycenax Biotech stock appears to be undervalued. The current stock price of NT$24.50 is trading 48.8% below its estimated GF Value™ of NT$47.88. GuruFocus considers Mycenax Biotech to be Possible Value Trap.

Key valuation signals for ROCO:4726:

  • FCF Margin %: 22.60%
  • GF Value™: NT$47.88 vs. price of NT$24.50 (48.8% below fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mycenax Biotech Business Description

Address No. 66, Shengyi 2nd Road, 7th Floor, Hsinchu Science Park, Hsinchu County, Zhubei, TWN, 302041
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards. The company's main operating region is located in Taiwan.
43GF Score

Get the complete analysis for ROCO:4726

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$24.50
Price
NT$47.88
GF Value